TherapeuticsMD, Inc. (TXMD): R&D Expense
Older than the company's other figures. The latest R&D Expense is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$7.09M
Year ended 2021-12-31
-36.2%
3-year compound annual growth
-33.4%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $7.09M | -32.1% | 2022-03-23, From 2021-01-01 |
| 2020-12-31 | $10.43M | -47.3% | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | $19.79M | -27.5% | 2022-03-23, From 2019-01-01 |
| 2018-12-31 | $27.30M | -19.4% | 2021-03-04, From 2018-01-01 |
| 2017-12-31 | $33.85M | -37.2% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $53.94M | -25.1% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $72.04M | +66.7% | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | $43.22M | +218.9% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $13.55M | +201.7% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $4.49M | n/m | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $107.2K | n/a | 2014-03-05, From 2011-01-01 |